Furthermore, the analysis of UCP-1 levels in the cell lysate highlights a positive trend in all the treatments.
← all excerpts
Development of an adipocyte differentiation protocol using 3T3-L1 cells for the investigation of the browning process: identification of the PPAR-γ agonist rosiglitazone as a browning reference drug.
2
—
—
The sentences
UCP-1 levels analyzed after 10 days of differentiation in the presence of RGZ 0.1 μM showed a positive trend that did not reach statistical significance, highlighting a higher variability than the data obtained on the 16th day.